Alveo Technologies is developing diagnostics for early detection of illness and disease. As is seen with the SARS-Cov-2 pandemic, infectious diseases affect everyone, everywhere. Alveo is addressing this problem by providing rapid, reliable and economical cloud-based diagnostics. To achieve this, Alveo condenses all the current diagnostic methods into a single-step process known as the be.well platform. The steps include sample preparation, nucleic acid amplification and real-time detection in a single isothermal microfluidic channel. Alveo hopes to use this information to track global infectious diseases by having at-home diagnostic results. The company is currently developing the platform for Flu A/B, COVID-19 and RSV. 

<p>Alveo Technologies is developing diagnostics for early detection of illness and disease. As is seen with the SARS-Cov-2 pandemic, infectious diseases affect everyone, everywhere. Alveo is addressing this problem by providing rapid, reliable and economical cloud-based diagnostics. To achieve this, Alveo condenses all the current diagnostic methods into a single-step process known as the be.well platform. The steps include sample preparation, nucleic acid amplification and real-time detection in a single isothermal microfluidic channel. Alveo hopes to use this information to track global infectious diseases by having at-home diagnostic results. The company is currently developing the platform for Flu A/B, COVID-19 and RSV. </p>


Alveo Technologies

Scientist III


                Development and Laboratory Validation of Rapid, Bird-Side Molecular Diagnostic Assays for Avian Influenza Virus Including Panzootic H5Nx
              


              California health department reports possible bird flu case in child
            

Alveo Technologies to develop avian influenza A(H5) test with CDC - LabPulse


              First known US case of person infected with new mpox strain reported
            

The State of Agricultural Testing With Shaun Holt, Alveo Technologies

 Corteva to collaborate with Alveo Technologies 

Anti-infective Injectable - DVM 360

Alveo Technologies Announces Major Distribution Expansion Across EMEA - PR Newswire

Keeping on top of avian influenza with on-farm testing - Poultry World

 Alveo Technologies and Corteva Agriscience Collaborate to Advance Molecular Crop Disease Diagnostics and Improve Crop Yields 

Diagnostic Company is Developing a Point of Need Spatial Multiplexed Test for Avian Influenza in Humans - Contagionlive.com

The Alveo platform enables early detection where it's needed most—on farms, in clinics, and in the field. Point of need molecular diagnostics can help prevent the spread of pathogens, reduce reliance on centralized labs, and protect both public and animal health. 

By delivering accurate results in real time, we’re supporting more informed decisions, minimizing disruption to food systems and ecosystems, and advancing a more sustainable, responsive approach to global health.

Learn more about us at https://lnkd.in/gqfsE3vH

 Alveo announces new distributor partnerships for EMEA region 

 Corteva, Alveo Technologies Form Collaboration to Advance Molecular Crop Disease Diagnostics 


              Wilted greens: How a leaf-eating pathogen, failed deals brought down Bowery Farming
            

Alveo Technologies and Royal GD Form Long-Term Partnership to Expand Joint Offerings for Rapid, Molecular Animal Diagnostics at Point-of-Need - PR Newswire

Early detection at the point of need can bridge gaps in monitoring, reduce the risk of outbreaks, and protect both public and animal health. Investing in innovative diagnostic strengthens global health systems against future threats. 

Alveo is focused on developing products to create a healthier and more sustainable future. Learn more about our platform and opportunities to work with us here: https://lnkd.in/g967KmRS

 Alveo's Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests 

 Flockscreen LAMP Avian Influenza Test for Poultry First Rapid Molecular Test to Accurately Detect the Presence of Virus in Both Cloacal and Oropharyngeal Samples 

 Alveo Technologies Announces Partner Program and Portal, New Enablement Software Suite, Further Empowering Partners in Co-Development of Advanced Molecular Diagnostics 

Alveo Technologies and Fraunhofer Partner to Develop First-of-its-Kind Rapid, Molecular Feline Respiratory Panel Diagnostic - PR Newswire

 Poultry Diagnostics Market to Reach US$ 847.6 Million with Growing at 8.5% CAGR by 2034 | Fact.MR Report 

 BioSpace Movers & Shakers, Sept. 18 

Alveo Technologies Inc. Wins Medlab Middle East's Inaugural Labpreneur Competition


              Grocers report egg shortage ahead of holidays amid surging bird flu
            

 Flockscreen LAMP Avian Influenza Test for Poultry First Rapid Molecular Test to Accurately Detect the Presence of ... 

Export Barbados (BIDC) signs MOU with Alveo Technologies, Inc. - Barbados Today

Testing a foundational piece of any strategy to combat avian influenza - Poultry World

Alveo Technologies Begins Shipping the First Point-of-Need™ Molecular Test for Avian Influenza in Poultry to the EU - PR Newswire

 Vial adaptor 

Alveo Technologies Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Advance At-Home Testing Platform for Viral Infectious Diseases - Business Wire

 Montana singer to perform National Anthem at CattleCon24 

 Alveo Technologies Enters Agreement with CDC to Develop a Point of Need Spatial Multiplexed Test for Avian Influenza A(H5) Virus in Humans 

Bringing medical-style in-field diagnostics to agriculture - Farm Progress

Alveo Technologies Inc wins Medlab Middle East’s inaugural Labpreneur competition - ZAWYA

Flockscreen LAMP Avian Influenza Test for Poultry First Rapid Molecular Test to Accurately Detect the Presence of Virus in Both Cloacal and Oropharyngeal Samples - PR Newswire

 Improvement in lamp amplification in a diagnostic device 

Avian flu confirmed in more US poultry, cattle; more than 500 herds now affected - University of Minnesota Twin Cities

Alveo Technologies Awarded Grant for its be.well™ COVID-19 Test - Business Wire

July Business Update: What’s new in the world of poultry? - Poultry World

 CDC Taps Alveo Technologies to Develop Avian Flu A(H5) Point-of-Need MDx 

Alveo Technologies Demonstrates its Rapid Avian Influenza Molecular Test Panel Detects Latest H5N1 Variants in Cattle and the Recent Human Infections in Colorado - PR Newswire

CDC taps Alveo for bird flu test development as H5N1 spreads - Medical Design & Outsourcing

 Bringing medical-style in-field diagnostics to agriculture ... 

What makes our platform different? In this brief clip, our CEO Shaun Holt explains why our IntelliSense technology, exceptional primer design and bioinformatics team, and the ability to test both oropharyngeal and cloacal samples on a single, portable device set us apart. This level of flexibility enables faster, more accurate detection directly in the field. With our Avian Influenza test, it is transforming how poultry producers and partners manage this ongoing global outbreak. 

Across other industries, our platform is used to help development partners know sooner and act faster.

Listen to the full clip below. 

Learn about our on-site avian influenza test here: https://lnkd.in/g9GFEdw5

 Alveo Technologies partnering to develop avian influenza molecular test 

New tech by Alveo re-envisions molecular diagnostics - World Health Expo

Heading

contact customer support here

Alveo Technologies Accelerates Partner Momentum for Rapid, Precision Testing Across Human, Agricultural, and Veterinary Applications

 Alveo Technologies Announces New Executive Leadership, Open Platform Strategy 

Vaccine progress swine influenza remains elusive, on-farm test is coming - Pig Progress

Alveo Technologies Appoints Nobel Laureate, Dr. James Rothman, to its Board of Directors - Business Wire

Alveo Technologies Enters Agreement with CDC to Develop a Point of Need Spatial Multiplexed Test for Avian Influenza A(H5) Virus in Humans

Poultry business update: What did you miss this October? - Poultry World

Rapid, highly-accurate on-farm HPAI testing coming - Poultry World

 Systems and methods of sample depositing and testing 


                Enhancing the response to avian influenza in the US and globally
              

 Alveo Technologies Announces Major Distribution Expansion Across EMEA 

 Alveo Technologies, NYtor to develop rapid test for swine influenza 

 Alveo Announces Appointments of CTO and Director of Assay Development 

 Nucleic acids for detection of infectious agents 

Alveo Technologies developed this groundbreaking product in partnership with x-Ovo, Royal 

Alveo Technologies Begins Shipping the First Point of Need™ Molecular Test for Avian Influ

Alveo Technologies, NYtor to develop rapid test for swine influenza - National Hog Farmer

 Alveo Technologies Demonstrates its Rapid Avian Influenza Molecular Test Panel Detects Latest H5N1 Variants in Cattle and the Recent Human Infections in Colorado 

 Alveo Technologies and Fraunhofer Partner to Develop First-of-its-Kind Rapid, Molecular Feline Respiratory Panel Diagnostic 

Alveo Technologies Enters Agreement with CDC to Develop a Point of Need Spatial Multiplexed Test for Avian Influenza A(H5) Virus in Humans - PR Newswire

ALVEO TECHNOLOGIES AND CORTEVA AGRISCIENCE COLLABORATE TO ADVANCE MOLECULAR CROP DISEASE DIAGNOSTICS AND IMPROVE CROP YIELDS - PR Newswire

Over the summer we announced the launch of the academic arm of our partner program, with the Global Virus Network as our inaugural partner. With input from leaders like Maggie Bartlett, we've designed a program to drive groundbreaking research and ultimately commercialize tests in regions with significant unmet needs. Learn more about partnering with us at the link below: https://lnkd.in/gH77iEEr 


                Our Investment in Alveo Technologies
              

According to the World Organisation for Animal Health, as of November 2024, over 30 mammal species have been infected with HPAI, a number that is expected to grow. "These cases further highlight the virus’s ability to cross species barriers and pose a threat to wildlife, domestic animals, and public health." 

We support their call for heightened surveillance in both domestic and wild bird populations, as well as expanded monitoring in mammals. Proactive detection and intervention are essential to mitigating the spread of this serious threat.

 Alveo Technologies and Royal GD Form Long-Term Partnership to Expand Joint Offerings for Rapid, Molecular Animal Diagnostics at Point-of-Need 

Alveo develops rapid, on-farm test for avian flu - Farm Progress


Investing in point of need molecular testing solutions is investing in a more secure and resilient future for food production.

Molecular diagnostics can play a role in creating a healthier and more sustainable future but mitigating risks to global food security. Enabling rapid, on-site detection of diseases in livestock and crops can help mitigate outbreaks before they escalate, reducing losses and ensuring a stable food supply. 

We believe that decentralizing diagnostics will empower all those working to grow, produce, and distribute food with actionable insights in real time, ultimately minimizing trade disruptions and protecting global food systems. 

Learn more about how our technology is putting the power of early detection in the hands of people working across industries and regions: https://lnkd.in/g967KmRS

CDC signs Alveo Technologies for fast, handheld test to detect avian flu in humans - Food Safety News

 Alveo Technologies Begins Shipping the First Point-of-Need™ Molecular Test for Avian Influenza in Poultry to the EU 

Alveo develops rapid test for avian flu - LabPulse

Alveo Technologies Partners with NYtor to Develop Rapid Molecular Test for the Dominant Swine Flu Strains

Corteva to Collaborate With Alveo Technologies - Successful Farming

Rapid test for bird flu developed - Food Safety News

 Alveo Technologies Is Developing Groundbreaking Avian Influenza Molecular Test for Poultry in Partnership with x ... 

 Alveo Technologies Welcomes Nobel Laureate to its Board 

We are on a mission to decentralize molecular diagnostics across a broad range of industries by enabling rapid decision making, timely action, and better outcomes at the point of need, with fast, easy-to-use, affordable, and accurate testing solutions.

Over the last 12 months, we've launched our Avian Influenza test for poultry with Royal GD, partnered with organizations and individuals, including Global Virus Network and Maggie Bartlett, to expand access to our platform to academic and research partners, and announced the development of new animal diagnostic tests with Fraunhofer IZI and NYtor.

We are dedicated to working towards our vision of a healthier and more sustainable future in 2025 with our partners old and new. Learn more about partnering with us here: https://lnkd.in/gH77iEEr


              Latest News and Insights | Alveo Technologies
            

New rapid test detects latest H5N1 variants in humans, cattle - AGDAILY

 People in the News at Haystack Oncology, Alveo Technologies, Biofidelity, Biocept, More 

 Alveo Technologies Partners with NYtor to Develop Rapid Molecular Test for the Dominant Swine Flu Strains 

 Alveo Technologies developing accurate, timely avian flu test 

 System and method for detection of nucleic acids 

Alveo Technologies Announces CE Mark for Its be.well COVID-19 Flex Test - Business Wire

Designed for use in the field, the Alveo Sense Poultry Avian Influenza Test delivers fast, accurate molecular results from cloacal or oropharyngeal samples in under 45 minutes at the Point of Need.

We are proud to have collaborated with Royal GD to bring this test to market. This partnership combines our proprietary IntelliSense™ technology and Bluetooth-enabled analyzer with Royal GD’s deep expertise in avian influenza, specifically, the critical design of multiple primer sets required to detect H5, H7, and H9 subtypes. 

In the video below, Sjaak De Wit shares more about the science behind the test and how this partnership came together.

California's H5N1 Emergency Declaration Highlights Need for an Urgent National Response to Avian Flu - HIT Consultant

 Alveo Technologies Appoints Nobel Laureate, Dr. James Rothman, to its Board of Directors 

Alveo Technologies and Royal GD Form Long-Term Partnership to Expand Joint Offerings for Rapid, Molecular Animal Diagnostics at Point of Need


              What’s Going on With All of These Food Recalls?
            

We’re proud to welcome Dr. James Rothman, Nobel Laureate in Physiology or Medicine, to Alveo Technologies’ Board of Directors. A pioneer in cell biology, Dr. Rothman brings decades of scientific leadership and innovation that will help guide Alveo as we expand the reach and impact of our molecular diagnostics platform across human, animal, and environmental health.

Read more: https://lnkd.in/gTpeMb4j

Alveo Technologies Launches Academic Partnership Program to Drive Innovation in Point-of-Need Molecular Diagnostics with Global Virus Network as Inaugural Partner - PR Newswire

Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets - Business Wire

Alveo Technologies

Business:

About: